Cost-effectiveness of levosimendan in patients with acute heart failure

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 4, 2011, Pages 363-366

  Fedele, Francesco ^a   D'Ambrosi, Alessandra ^a   Bruno, Noemi ^a   Caira, Carmen ^a   Brasolin, Bruno ^a   Mancone, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

acute heart failure; hospitalization costs; inodilator therapy; rehospitalization rate; survival

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; FEMALE; HOSPITAL READMISSION; HUMAN; INOTROPISM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION;

ACUTE DISEASE; AGED; CARDIOTONIC AGENTS; COST-BENEFIT ANALYSIS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYDRAZONES; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PYRIDAZINES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80053992114     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318224e0a2     Document Type: Article

References (15)

1. Zannad F. Acute heart failure syndromes: the 'Cinderella' of heart failure research. Eur Heart J. 2005;7(suppl 7):B8-B12. (Pubitemid 40516890)
2. Gigli G, Lispi L, Donati C, et al. Trends in hospitalization for heart failure in Italy 2001-2003. J Cardiovasc Med (Hagerstown). 2009;10:367-371.
3. Nieminen MS, Böhm M, Cowie MR, et al; ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416. (Pubitemid 40283098)
4. Nieminen MS, Pollesello P, Vajda G, et al. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol. 2009;53:302-310.
5. Delaney A, Bradford C, McCaffrey J, et al. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials. Int J Cardiol. 2010;138:281-289.
6. Follath F, Cleland JG, Just H, et al. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised doubleblind trial. Lancet. 2002;360:196-202. (Pubitemid 34804646)
7. Cleland JGF, Takala A, Apajasalo M, et al. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe lowoutput heart failure: an analysis based on the international LIDO trial. Eur J Heart Fail. 2003;5:101-108. (Pubitemid 36205551)
8. Tavazzi L, Maggioni AP, Lucci D, et al; Italian survey on Acute Heart Failure Investigators. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207-1215.
9. Tan SS, Martin J, Pezzi A, et al. Microcosting study of ICU costs in three European countries. Crit Care. 2008;12(suppl 2):P526. doi:10.1186/ cc6747.
10. Oliveira MT Jr, Follador W, Martins ML, et al. Cost analysis of the treatment of acute decompensated heart failure. levosimendan versus dobutamine. Arq Bras Cardiol. 2005;85:9-14. (Pubitemid 41025799)
11. de Lissovoy G, Fraeman K, Salon J, et al. The costs of treating acute heart failure: an economic analysis of the SURVIVE trial. J Med Econ. 2008;11: 415-429.
12. de Lissovoy G, Fraeman K, Teerlink JR, et al. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study. Eur J Health Econ. 2010;11:185-193.
13. Yilmaz MB, Yontar C, Erdem A, et al. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Heart Vessels. 2009;24:16-21.
14. Kamalesh M, Cleophas TJ. Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects. J Card Fail. 2009;15305-15309.
15. Ribeiro RA, Paim Rohd LE, Polanczyk CA. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis. Arq Bras Cardiol. 2010;95:230-237.